328 related articles for article (PubMed ID: 19666099)
61. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
62. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
[TBL] [Abstract][Full Text] [Related]
63. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti.
Yarin YM; Amarjargal N; Fuchs J; Haupt H; Mazurek B; Morozova SV; Gross J
Hear Res; 2005 Mar; 201(1-2):1-9. PubMed ID: 15721555
[TBL] [Abstract][Full Text] [Related]
64. Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.
Carmichael J; Sugars KL; Bao YP; Rubinsztein DC
J Biol Chem; 2002 Sep; 277(37):33791-8. PubMed ID: 12097329
[TBL] [Abstract][Full Text] [Related]
65. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
[TBL] [Abstract][Full Text] [Related]
66. Inhibiting glycogen synthase kinase 3beta in sepsis.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala E; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Novartis Found Symp; 2007; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
[TBL] [Abstract][Full Text] [Related]
67. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.
Roldán-Fidalgo A; Martín Saldaña S; Trinidad A; Olmedilla-Alonso B; Rodríguez-Valiente A; García-Berrocal JR; Ramírez-Camacho R
Exp Toxicol Pathol; 2016 Apr; 68(4):197-204. PubMed ID: 26850526
[TBL] [Abstract][Full Text] [Related]
68. GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells.
Wu YY; Hsieh CT; Chiu YM; Chou SC; Kao JT; Shieh DC; Lee YJ
PLoS One; 2018; 13(12):e0208094. PubMed ID: 30557366
[TBL] [Abstract][Full Text] [Related]
69. A low-dose regimen of cisplatin before high-dose cisplatin potentiates ototoxicity.
Harrison RT; DeBacker JR; Bielefeld EC
Laryngoscope; 2015 Feb; 125(2):E78-83. PubMed ID: 25267530
[TBL] [Abstract][Full Text] [Related]
70. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
Menon B; Johnson JN; Ross RS; Singh M; Singh K
J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
[TBL] [Abstract][Full Text] [Related]
71. Ablation of mixed lineage kinase 3 (Mlk3) does not inhibit ototoxicity induced by acoustic trauma or aminoglycoside exposure.
Polesskaya O; Cunningham LL; Francis SP; Luebke AE; Zhu X; Collins D; Vasilyeva ON; Sahler J; Desmet EA; Gelbard HA; Maggirwar SB; Walton JP; Frisina RD; Dewhurst S
Hear Res; 2010 Dec; 270(1-2):21-7. PubMed ID: 20971179
[TBL] [Abstract][Full Text] [Related]
72. [Reduced nutritional status enhances ototoxicity].
Lautermann J; Schacht J
Laryngorhinootologie; 1995 Dec; 74(12):724-7. PubMed ID: 8579670
[TBL] [Abstract][Full Text] [Related]
73. Modulation of the development of human monocyte-derived dendritic cells by lithium chloride.
Liu KJ; Lee YL; Yang YY; Shih NY; Ho CC; Wu YC; Huang TS; Huang MC; Liu HC; Shen WW; Leu SJ
J Cell Physiol; 2011 Feb; 226(2):424-33. PubMed ID: 20672290
[TBL] [Abstract][Full Text] [Related]
74. Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice.
He J; Yin S; Wang J; Ding D; Jiang H
Acta Otolaryngol; 2009 Dec; 129(12):1359-67. PubMed ID: 19922082
[TBL] [Abstract][Full Text] [Related]
75. Pharmaceutical inhibition of glycogen synthetase kinase 3 beta suppresses wear debris-induced osteolysis.
Geng D; Wu J; Shao H; Zhu S; Wang Y; Zhang W; Ping Z; Hu X; Zhu X; Xu Y; Yang H
Biomaterials; 2015 Nov; 69():12-21. PubMed ID: 26275858
[TBL] [Abstract][Full Text] [Related]
76. Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production.
Zhang W; Xiong H; Pang J; Su Z; Lai L; Lin H; Jian B; He W; Yang H; Zheng Y
Toxicol Lett; 2020 Oct; 331():1-10. PubMed ID: 32428544
[TBL] [Abstract][Full Text] [Related]
77. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.
Thotala DK; Geng L; Dickey AK; Hallahan DE; Yazlovitskaya EM
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):557-65. PubMed ID: 20117291
[TBL] [Abstract][Full Text] [Related]
78. Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells.
Choi BM; Chen XY; Gao SS; Zhu R; Kim BR
Pharmacol Rep; 2011; 63(3):708-16. PubMed ID: 21857081
[TBL] [Abstract][Full Text] [Related]
79. Otoprotective properties of mannitol against gentamicin induced hair cell loss.
Wood JW; Bas E; Gupta C; Selman Y; Eshraghi A; Telischi FF; Van De Water TR
Otol Neurotol; 2014 Jun; 35(5):e187-94. PubMed ID: 24662629
[TBL] [Abstract][Full Text] [Related]
80. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation.
Datusalia AK; Sharma SS
Mol Neurobiol; 2014 Oct; 50(2):390-405. PubMed ID: 24420785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
